Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00110721
Status:
TERMINATED
Last Update Posted:
2012-03-06
First Post:
2005-05-12
Brief Title:
GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer
Sponsor:
Galectin Therapeutics Inc
Organization:
Galectin Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-05
Start Date Type:
None
Primary Completion Date:
2007-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-02
Completion Date Type:
ACTUAL
First Submit Date:
2005-05-12
First Submit QC Date:
May 12 2005
Study First Post Date:
2005-05-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-03-05
Last Update Post Date:
2012-03-06
Last Update Post Date Type:
ESTIMATED